
Mark Painter
379 posts

Mark Painter
@markmpainter
Postdoc immunologist with @EJohnWherry at Penn, studying immune responses to SARS-CoV-2, viral infections, Long COVID, and beyond





Excited to share my graduate work from the @EJohnWherry lab on the molecular mechanisms locking in the differentiation fate of exhausted CD8 T cells (Tex), published earlier this month in @SciImmuno. Main findings below! science.org/doi/10.1126/sc…

Excited to share my graduate work from the @EJohnWherry lab on the molecular mechanisms locking in the differentiation fate of exhausted CD8 T cells (Tex), published earlier this month in @SciImmuno. Main findings below! science.org/doi/10.1126/sc…






Check out our latest paper “Differentiation fate of a stem-like CD4 T cell control immunity to cancer”, led by @Maria_Carden1 now live @Nature tinyurl.com/33d24k89 . This work examines how CD4 T cell differentiation dictates the outcome of the cancer response. Thread below


The IEDB Virtual User Workshop starts in 3 weeks! Register now so you don't miss out on hearing from our wonderful PIs @SetteLab and @BjoernPeters2, team members @jgbaum @ZeynepK_Y @mahitajarjapu @Alba_Grifoni @EveRichardson20 @danielmarrama & many more! surveymonkey.com/r/IEDBUW2024







#LongCOVID causes perturbations that persist from 12 wks to >2 years, but does this impact #Tcells? Our study @PNAS from @KedzeriskaLab @DohertyInst defines long COVID T&B cell responses over 24 mths from epitope specificity to TCR clonotype doi.org/10.1073/pnas.2…



